An observational, non-interventional, multi-center study to evaluate efficacy and tolerability of high dose rosuvastatin in high risk patients after titration.

Trial Profile

An observational, non-interventional, multi-center study to evaluate efficacy and tolerability of high dose rosuvastatin in high risk patients after titration.

Completed
Phase of Trial: Phase III

Latest Information Update: 19 Mar 2012

At a glance

  • Drugs Rosuvastatin (Primary)
  • Indications Hyperlipidaemia
  • Focus Therapeutic Use
  • Acronyms REVORUTION
  • Sponsors AstraZeneca
  • Most Recent Events

    • 19 Mar 2012 Actual patient number (1482) added as reported by ClinicalTrials.gov.
    • 30 Nov 2010 Actual initiation date changed from Aug 2007 to May 2007 as reported by ClinicalTrials.gov.
    • 14 Oct 2008 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top